Xin Huang

This study uses a genome-wide CRISPR/Cas9 knockout screen in bovine cells to identify host factors essential for BPIV3 replication, revealing SLC35A1 and LSM12 as critical for viral entry.

This study develops a nanodrug, mPDS@CAR-M, for targeted treatment of RAIR-DTC by combining chemotherapy, photothermal therapy, and tumor cell membrane coating to enhance tumor targeting and therapeutic efficacy.

This paper develops a drug delivery system to overcome chemoresistance in osteosarcoma by combining photothermal therapy and dual drug delivery with targeted nuclear release.